Loading...
Results of a UK real world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory large B-cell lymphoma
Northend, M. Wilson, W. Osborne, W. Fox, C. P. Davies, A. J. El-Sharkawi, D. Phillips, E. H. Sim, H. W. Sadullah, S. Shah, N.
Northend, M.
Wilson, W.
Osborne, W.
Fox, C. P.
Davies, A. J.
El-Sharkawi, D.
Phillips, E. H.
Sim, H. W.
Sadullah, S.
Shah, N.
Citations
Altmetric:
Abstract
Authors
Northend, M.
Wilson, W.
Osborne, W.
Fox, C. P.
Davies, A. J.
El-Sharkawi, D.
Phillips, E. H.
Sim, H. W.
Sadullah, S.
Shah, N.
Peng, Y. Y.
Qureshi, I.
Addada, J.
Mora, R. F.
Phillips, N.
Kuhnl, A.
Davies, E.
Wrench, D. J.
McKay, P.
Karpha, I.
Cowley, A.
Karim, R.
Challenor, S.
Singh, V.
Burton, C.
Auer, R.
Williams, C.
Cunningham, J.
Broom, A.
Arasaretnam, A.
Roddie, C.
Menne, T.
Townsend, W. M.
Wilson, W.
Osborne, W.
Fox, C. P.
Davies, A. J.
El-Sharkawi, D.
Phillips, E. H.
Sim, H. W.
Sadullah, S.
Shah, N.
Peng, Y. Y.
Qureshi, I.
Addada, J.
Mora, R. F.
Phillips, N.
Kuhnl, A.
Davies, E.
Wrench, D. J.
McKay, P.
Karpha, I.
Cowley, A.
Karim, R.
Challenor, S.
Singh, V.
Burton, C.
Auer, R.
Williams, C.
Cunningham, J.
Broom, A.
Arasaretnam, A.
Roddie, C.
Menne, T.
Townsend, W. M.
Description
Date
2022
Publisher
Collections
Files
Loading...
From UNPAYWALL
Adobe PDF, 1.28 MB
Keywords
Type
Other
Citation
Northend M, Wilson W, Osborne W, Fox CP, Davies AJ, El-Sharkawi D, et al. Results of a UK real world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory large B-cell lymphoma. Blood Advances. American Society of Hematology; 2022.